Replies to post #280119 on NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

I validated nothing.

Let me invalidate some of your post.

Would investors be better off if nwbo had sold out five years ago? Yes, and dramatically so. 5/1/2017 nwbo price was $8.40, with a much smaller base of shares outstanding. nwbo was flush with cash from the sales to Woodford. Raising cash was relatively easy.

The subsequent value destruction over the past 5 years is stunning.

A new trial would have treated ~400 patients, mostly at top teaching hospitals. Even if dcvax does nothing, SOC at such hospitals is probably better than whatever happened. Instead, ZERO new patients treated.